| DC Field | Value | Language |
|---|
| dc.contributor.author | Deigin, V. | - |
| dc.contributor.author | Vinogradova, Yu. | - |
| dc.contributor.author | Vinogradov, D. | - |
| dc.contributor.author | Linkova, N. | - |
| dc.contributor.author | Dyatlova, A. | - |
| dc.date.accessioned | 2025-08-28T09:05:08Z | - |
| dc.date.available | 2025-08-28T09:05:08Z | - |
| dc.date.issued | 2024 | - |
| dc.identifier.citation | Novel peptidomimetic cyclo-{E(I)-E(W)}Na (CP-88) with hematopoietic activity sustained in invasive and oral administration: experimental and preclinical evaluation / V. Deigin, Vinogradova Yu., D. Vinogradov [et al.] // International Journal of Molecular Sciences. - 2024. - Vol.25, №24.-Art. 13385. - Doi: 10.3390/ijms252413385. | ru |
| dc.identifier.uri | http://dspace.bsuedu.ru/handle/123456789/65374 | - |
| dc.description.abstract | The aim of this work is to study novel peptidomimetics with hematopoietic activity sustained in invasive and oral administration. The results of this investigation underscore the significant potential of CP-88 peptide as a hematopoiesis-regulated drug and instill optimism for its future application in medical practice | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | pharmacology | ru |
| dc.subject | CP-88 peptide | ru |
| dc.subject | peptidomimetics | ru |
| dc.subject | cyclopeptides | ru |
| dc.subject | hematopoiesis | ru |
| dc.subject | hematopoietic activity | ru |
| dc.title | Novel peptidomimetic cyclo-{E(I)-E(W)}Na (CP-88) with hematopoietic activity sustained in invasive and oral administration: experimental and preclinical evaluation | ru |
| dc.type | Article | ru |
| Appears in Collections: | Статьи из периодических изданий и сборников (на иностранных языках) = Articles from periodicals and collections (in foreign languages)
|
